Brought to you by 
Berlex/Metra/Norland form women's health consortium
09 May 2002
Executive Summary
Metra Biosystems will pay Schering AG's Berlex Labs to co-promote Metra's Pyrilinks-D bone resorption urine-based immunoassay; the two companies will also co-promote Norland Medical's bone densitometry systems.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Diagnostic Imaging Equipment & Supplies
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Urine-based Testing
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Disease Management
- Includes Equity
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Berlex/Metra/Norland form women's health consortium
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice